169 related articles for article (PubMed ID: 35922954)
1. [Treatment strategy for acute lymphoblastic leukemia in adolescent and young adults].
Yamazaki E
Rinsho Ketsueki; 2022; 63(7):826-832. PubMed ID: 35922954
[TBL] [Abstract][Full Text] [Related]
2. Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Testi AM; Canichella M; Vitale A; Piciocchi A; Guarini A; Starza ID; Cavalli M; De Propris MS; Messina M; Elia L; Moleti ML; Martino B; Luppi M; D'Aloisio M; Candoni A; Conter V; Fazi P; Vignetti M; Chiaretti S; Foà R
Am J Hematol; 2021 Mar; 96(3):292-301. PubMed ID: 33284999
[TBL] [Abstract][Full Text] [Related]
3. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.
Ram R; Wolach O; Vidal L; Gafter-Gvili A; Shpilberg O; Raanani P
Am J Hematol; 2012 May; 87(5):472-8. PubMed ID: 22388572
[TBL] [Abstract][Full Text] [Related]
4. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Ribera JM; Morgades M; Montesinos P; Tormo M; Martínez-Carballeira D; González-Campos J; Gil C; Barba P; García-Boyero R; Coll R; Pedreño M; Ribera J; Mercadal S; Vives S; Novo A; Genescà E; Hernández-Rivas JM; Bergua J; Amigo ML; Vall-Llovera F; Martínez-Sánchez P; Calbacho M; García-Cadenas I; Garcia-Guiñon A; Sánchez-Sánchez MJ; Cervera M; Feliu E; Orfao A;
Cancer Med; 2020 Apr; 9(7):2317-2329. PubMed ID: 32022463
[TBL] [Abstract][Full Text] [Related]
5. Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Muffly L; Lichtensztajn D; Shiraz P; Abrahão R; McNeer J; Stock W; Keegan T; Gomez SL
Cancer; 2017 Jan; 123(1):122-130. PubMed ID: 27622953
[TBL] [Abstract][Full Text] [Related]
6. How I treat acute lymphoblastic leukemia in older adolescents and young adults.
Curran E; Stock W
Blood; 2015 Jun; 125(24):3702-10. PubMed ID: 25805810
[TBL] [Abstract][Full Text] [Related]
7. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.
Orellana-Noia VM; Douvas MG
Curr Hematol Malig Rep; 2018 Apr; 13(2):100-108. PubMed ID: 29442287
[TBL] [Abstract][Full Text] [Related]
8. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
[TBL] [Abstract][Full Text] [Related]
9. [Acute lymphoblastic leukemia in adolescents and young adults].
Hayakawa F
Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia in adolescents and young adults.
Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM
Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172
[TBL] [Abstract][Full Text] [Related]
11. The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations.
Jain H; Rajendra A; Sengar M; Goli VB; Thorat J; Muthuluri H; Tongaonkar AH; Kota KK; Gupta H; Sharma N; Eipe T; Mehta H
Expert Rev Anticancer Ther; 2022 Aug; 22(8):845-860. PubMed ID: 35734814
[TBL] [Abstract][Full Text] [Related]
12. Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
Hanbali A; Kotb A; El Fakih R; Alfraih F; Ahmed SO; Shaheen M; Hashmi S; Alhayli S; Alahmari A; Riash MA; Rasheed W; Alzahrani H; Alsharif F; Chaudhri N; Almohareb F; Aljurf M
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):670-677. PubMed ID: 31377206
[TBL] [Abstract][Full Text] [Related]
13. [The treatment development for T cell acute lymphoblastic leukemia in children, adolescents, and young adults].
Sato A
Rinsho Ketsueki; 2022; 63(9):1325-1334. PubMed ID: 36198559
[TBL] [Abstract][Full Text] [Related]
14. [Acute lymphoblastic leukemia in adolescents and young adults: from the viewpoint of pediatricians].
Koh K
Rinsho Ketsueki; 2017; 58(8):1024-1030. PubMed ID: 28883265
[TBL] [Abstract][Full Text] [Related]
15. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.
Gupta S; Pole JD; Baxter NN; Sutradhar R; Lau C; Nagamuthu C; Nathan PC
Cancer Med; 2019 May; 8(5):2095-2103. PubMed ID: 30912628
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.
White VM; Skaczkowski G; Pinkerton R; Coory M; Osborn M; Bibby H; Nicholls W; Orme LM; Conyers R; Phillips MB; Harrup R; Walker R; Thompson K; Anazodo A
Pediatr Blood Cancer; 2018 Nov; 65(11):e27349. PubMed ID: 30039912
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience.
Elashtokhy HEA; Elgohary HE; Eldeep BB; Gaber SM; Elbedewy TA
J Egypt Natl Canc Inst; 2021 Apr; 33(1):9. PubMed ID: 33826046
[TBL] [Abstract][Full Text] [Related]
18. Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
Rytting ME; Jabbour EJ; Jorgensen JL; Ravandi F; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Borthakur G; Garris R; Wang S; Pierce S; Schroeder K; Kornblau SM; Thomas DA; Cortes JE; O'Brien SM; Kantarjian HM
Am J Hematol; 2016 Aug; 91(8):819-23. PubMed ID: 27178680
[TBL] [Abstract][Full Text] [Related]
19. Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).
Rytting ME; Thomas DA; O'Brien SM; Ravandi-Kashani F; Jabbour EJ; Franklin AR; Kadia TM; Pemmaraju N; Daver NG; Ferrajoli A; Garcia-Manero G; Konopleva MY; Cortes JE; Borthakur G; Garris R; Cardenas-Turanzas M; Schroeder K; Jorgensen JL; Kornblau SM; Kantarjian HM
Cancer; 2014 Dec; 120(23):3660-8. PubMed ID: 25042398
[TBL] [Abstract][Full Text] [Related]
20. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
Lukenbill J; Advani AS
Curr Hematol Malig Rep; 2013 Jun; 8(2):91-7. PubMed ID: 23559026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]